Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Brilaroxazine hydrochloride by Reviva Pharmaceuticals for Major Depressive Disorder: Likelihood of Approval
Brilaroxazine hydrochloride is under clinical development by Reviva Pharmaceuticals and currently in Phase I for Major Depressive Disorder. According to...
Data Insights
Brilaroxazine hydrochloride by Reviva Pharmaceuticals for Schizophrenia: Likelihood of Approval
Brilaroxazine hydrochloride is under clinical development by Reviva Pharmaceuticals and currently in Phase III for Schizophrenia. According to GlobalData, Phase...